ADVIL ALLERGY SINUS

LOE Approaching

chlorpheniramine maleate, ibuprofen, pseudoephedrine hcl

GSK
NDAORALTABLET
Approved
Dec 2002
Lifecycle
LOE Approaching
Competitive Pressure
25/100

Mechanism of Action

Cyclooxygenase Inhibitors

Pharmacologic Class:

Nonsteroidal Anti-inflammatory Drug

Indications (6)

these symptoms associated with hay feverother upper respiratory allergiesthe common cold: runny nose itchywatery eyes itching of the nosethroat sneezing nasal congestion sinus pressure headache minor achespains fever

Loss of Exclusivity

LOE Date
Feb 28, 2027
12 months away
Patent Expiry
Feb 28, 2027

Patent Records (1)

Patent #ExpiryTypeUse Code
7863287
Feb 28, 2027
Product
—
Company
GSK
GSK
LONDON, United Kingdom
702 open jobs
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers